BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37998581)

  • 1. The Usefulness of the Eosinophilic Esophagitis Histology Scoring System in Predicting Response to Proton Pump Inhibitor Monotherapy in Children with Eosinophilic Esophagitis.
    Jevtić J; Ristić N; Pavlović V; Svorcan J; Milovanovich I; Radusinović M; Popovac N; Simić L; Ćirović A; Đuknić M; Životić M; Poljašević N; Obradović D; Filipović J; Janković R
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the Eosinophilic Esophagitis Histologic Scoring System in Distinguishing Active Eosinophilic Esophagitis From Remission and Gastroesophageal Reflux Disease.
    Lin B; Rabinowitz S; Haseeb MA; Gupta R
    Gastroenterology Res; 2021 Aug; 14(4):220-226. PubMed ID: 34527091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors.
    Vieira GG; Ribeiro LBM; Truppel SK; Rosário Filho NA; Vieira MC
    J Pediatr (Rio J); 2020; 96(5):638-643. PubMed ID: 31361987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the Eosinophilic Esophagitis Histology Scoring System Grade Scores in Patients at British Columbia Children's Hospital.
    Cruz J; Irvine MA; Avinashi V; Chan ES; Vallance BA; Soller L; Bush JW
    Fetal Pediatr Pathol; 2022 Dec; 41(6):962-976. PubMed ID: 35094661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of endoscopic signs and mucosal alterations in children with eosinophilic esophagitis.
    Hiremath G; Correa H; Acra S; Dellon ES
    Gastrointest Endosc; 2020 Apr; 91(4):785-794.e1. PubMed ID: 31785273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic esophagitis: Comparison of clinical, endoscopic and histological scoring systems.
    Lorenz NJ; Link A; Czapiewski P; Arnim UV
    Z Gastroenterol; 2022 Dec; 60(12):1779-1786. PubMed ID: 36417921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic Esophagitis Histologic Scoring System: Correlation with Histologic, Endoscopic, and Symptomatic Disease and Clinical Use.
    Alexander RG; Ravi K; Collins MH; Lavey CJ; Snyder DL; Lennon RJ; Kassmeyer BA; Katzka DA; Alexander JA
    Dig Dis Sci; 2023 Sep; 68(9):3573-3583. PubMed ID: 37432533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis.
    Maslenkina K; Mikhaleva L; Mikhalev A; Kaibysheva V; Atiakshin D; Motilev E; Buchwalow I; Tiemann M
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis.
    Hiremath G; Sun L; Collins MH; Bonis PA; Arva NC; Capocelli KE; Chehade M; Davis CM; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Khoury P; Mukkada VA; Martin LJ; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME; Koyama T; Dellon ES
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2807-2816.e3. PubMed ID: 36967100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
    Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Román E
    Front Pediatr; 2018; 6():119. PubMed ID: 29868522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.
    Slack IF; Schwartz JT; Mukkada VA; Hottinger S; Abonia JP
    Curr Allergy Asthma Rep; 2020 Jun; 20(8):30. PubMed ID: 32506181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 May; ():. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomorphological criteria and features of immune response in eosinophilic esophagitis and reflux esophagitis].
    Maslenkina KS; Motylev EN; Guschin MY; Vandysheva RA; Mikhaleva LM
    Arkh Patol; 2024; 86(1):5-12. PubMed ID: 38319266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and interobserver agreement of histopathological findings in pediatric patients with eosinophilic esophagitis.
    Vieira MC; Gugelmin ES; Percicote AP; Ribeiro MG; de Miranda RA; Vieira GG; Ribeiro LBM; Truppel SK; Filho NAR
    J Pediatr (Rio J); 2022; 98(1):26-32. PubMed ID: 33964213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice.
    Asher Wolf W; Dellon ES
    Gastroenterol Hepatol (N Y); 2014 Jul; 10(7):427-32. PubMed ID: 25904830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.